Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi studyFor the DELPHI Serenity Group
Authors 22
-
Isabelle Mahé corresponding
-
Affiliation as printed
Aalborg University Hospital
Aalborg University Hospital, Denmark
-
Johannes Gutenberg University Mainz · University Medical Center of the Johannes Gutenberg University Mainz
Affiliation as printed
University Medical Center of the Johannes GutenbergUniversity Mainz - Center for Thrombosis and Hemostasis (CTH)
University Medical Center of the Johannes GutenbergUniversity Mainz - Center for Thrombosis and Hemostasis (CTH), Germany
-
Erasmus MC · Erasmus University Rotterdam
Affiliation as printed
Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC)
-
Affiliation as printed
King’s College London
-
University of Hull · Hull York Medical School
Affiliation as printed
University of Hull - Hull York Medical School
University of Hull - Hull York Medical School, Hull, United Kingdom
-
Johanneke E.A. Portielje Aachen
Leiden University · Leiden University Medical Center
Affiliation as printed
Leiden University - Leiden University Medical Center (LUMC)
-
Stella Trompet Aachen
Affiliation as printed
Leiden University - Department of Cardiology
Leiden University - Department of Cardiology, Leiden, Netherlands
-
Frederikus Albertus Klok Aachen
Leiden University · Leiden University Medical Center
Affiliation as printed
Leiden University - Leiden University Medical Center (LUMC)
Cited by 0 stored of 0
No patents citing this paper on Lens.org (checked 2026-10-11).